ALHEMO sol inj 60 mg/1.5ml stylo pré 1.5 ml
7680688440027
CH-68844
B02BX
06.01.1.
Reimbursement limitations:
ALHEMO.01
Patients atteints d’hémophilie A avec inhibiteurs
Pour la prophylaxie des épisodes hémorragiques chez les patients …
1 / 3
google
Details
- Product number
- 6884402
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigpen
- Composition
- concizumabum 40 mg, histidinum, arginini hydrochloridum, natrii chloridum, saccharum, polysorbatum 80, phenolum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1.0 ml corresp. natrium max. 0.0362 mmol.
Articles (1)
Alhemo 60 mg/1.5 ml, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
40.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 4374.15
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2024
Authorization holder
Novo Nordisk Pharma AG
8302 Kloten
Authorization information
- Swissmedic authorization number
- 68844
- Drug name
- Alhemo, Injektionslösung im Fertigpen
- Galenic form
- INLFP
- ATC Code
- B02BX
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 08/08/2023
- Authorization expiration date
- 07/08/2028
- IT number
- 06.01.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ALHEMO sol inj 60 mg/1.5ml stylo pré 1.5 ml
- Description (DE)
- ALHEMO Inj Lös 60 mg/1.5ml Fertpen 1.5 ml
- Market launch
- 08/08/2023
- Narcotic (BTM)
- No